Characterisation and Sensitivity of a Canine Mast Cell Tumour Line to Oncolytic Viruses

被引：0

作者：

Mehrani, Yeganeh ^{[1
]}

Kakish, Julia E. ^{[1
]}

Napoleoni, Christina ^{[1
]}

Thompson, Jennifer Jane ^{[1
]}

Knapp, Jason P. ^{[1
]}

Minott, Jessica A. ^{[1
]}

Yates, Jacob G. E. ^{[1
]}

Stuart, Deirdre ^{[2
]}

Coomber, Brenda L. ^{[3
]}

Foster, Robert A. ^{[1
]}

Bridle, Byram W. ^{[1
]}

Karimi, Khalil ^{[1
]}

机构：

[1] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada

[2] Univ Guelph, Ontario Vet Coll, Compan Anim Tumour Bank, Guelph, ON, Canada

[3] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON, Canada

来源：

VETERINARY AND COMPARATIVE ONCOLOGY | 2025年 / 23卷 / 01期

关键词：

cancer; canine mast cell tumours; oncolytic virotherapy; oncolytic viruses; SURVIVAL; ORFV;

D O I：

10.1111/vco.13024

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

Canine mast cell tumours (MCTs) are one of the most common skin cancers of dogs. Surgical removal is the primary treatment, but recurrence and metastasis can occur even with low-grade tumours. As a result, new treatment strategies are being sought. We tested the potential of several oncolytic viruses (OVs) to infect and kill a cell line isolated from a canine MCT. Employing a resazurin-based metabolic assay and flow cytometry technology, we used recombinant vesicular stomatitis virus (rVSV-Delta m51), avian orthoavulavirus-1 (AOaV-1), and Orf viruses in our assessment. Our study aimed to evaluate the potential of oncolytic virotherapy in treating canine cancers. We found that MCT-1 cells showed different sensitivities to the OVs, with rVSV-Delta m51 showing the most promising results in vitro. These findings suggest that further investigation into using OVs for treating canine MCTs is needed, although clinical efficacy is yet to be determined.

引用

页码：42 / 51

页数：10

共 50 条

[31] COX-2 and mPGES-1 expression in canine mast cell tumour
Kandefer-Gola, Malgorzata
Nowak, Marcin
Dzimira, Stanislaw
Janus, Izabela
Ciaputa, Rafal
Madej, Janusz A.
MEDYCYNA WETERYNARYJNA-VETERINARY MEDICINE-SCIENCE AND PRACTICE, 2015, 71 (06): : 345 - 348
[32] Occurrence and distribution of canine cutaneous mast cell tumour characteristics among predisposed breeds
Smiech, Anna
Lopuszynski, Wojciech
Slaska, Brygida
Bulak, Kamila
Jasik, Agnieszka
JOURNAL OF VETERINARY RESEARCH, 2019, 63 (01) : 141 - 148
[33] Breed predispositions in canine mast cell tumour: A single centre experience in the United Kingdom
Warland, James
Dobson, Jane
VETERINARY JOURNAL, 2013, 197 (02): : 496 - 498
[34] Plasma VEGF levels correlated with malignancy grade in canine mast cell tumour model
Patruno, R.
Coviello, M.
Zizzo, N.
Quaranta, M.
Gadaleta, C.
Ranieri, G.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 132 - 132
[35] Canine Transmissible Venereal Tumour: Asessment of Mast Cell Numbers as Indicators of the Growth Phase
S. Mukaratirwa
T. Chiwome
S. Chitanga
E. Bhebhe
Veterinary Research Communications, 2006, 30 : 613 - 621
[36] Canine transmissible venereal tumour: Asessment of mast cell numbers as indicators of the growth phase
Mukaratirwa, S.
Chiwome, T.
Chitanga, S.
Bhebhe, E.
VETERINARY RESEARCH COMMUNICATIONS, 2006, 30 (06) : 613 - 621
[37] COMPARATIVE SENSITIVITY OF BGM CELL LINE FOR ISOLATION OF ENTERIC VIRUSES
SCHMIDT, NJ
HO, HH
LENNETTE, EH
HEALTH LABORATORY SCIENCE, 1976, 13 (02) : 115 - 117
[38] CANINE MAST CELL DISEASES
COOK, JE
NATIONAL CANCER INSTITUTE MONOGRAPHS, 1969, (32): : 267 - &
[39] CANINE MAST CELL LEUKEMIA
POST, JE
NORONHA, F
RICKARD, CG
BIBLIOTHECA HAEMATOLOGICA, 1970, 1969 (36): : 425 - +
[40] Redirecting oncolytic viruses: Engineering opportunists to take control of the tumour microenvironment
Jamieson, Taylor R.
Poutou, Joanna
Ilkow, Carolina S.
CYTOKINE & GROWTH FACTOR REVIEWS, 2020, 56 : 102 - 114

← 1 2 3 4 5 →